三生国健股价涨5.08%，工银瑞信基金旗下1只基金位居十大流通股东，持有319.9万股浮盈赚取815.76万元

Group 1 - The core viewpoint of the news is that Sanofi Guojian's stock price increased by 5.08%, reaching 52.70 CNY per share, with a total market capitalization of 32.505 billion CNY [1] - Sanofi Guojian Pharmaceutical Co., Ltd. is located in the China (Shanghai) Pilot Free Trade Zone and was established on January 25, 2002, with its listing date on July 22, 2020 [1] - The company's main business involves the research, production, and sales of antibody drugs, with revenue composition as follows: 75.24% from product sales, 15.37% from commissioned processing services, 7.94% from licensing services, and 1.44% from leasing services [1] Group 2 - Among the top ten circulating shareholders of Sanofi Guojian, a fund under ICBC Credit Suisse Asset Management has entered the list, holding 3.199 million shares, which accounts for 0.52% of the circulating shares [2] - The ICBC Frontier Medical Stock A fund (001717) was established on February 3, 2016, with a latest scale of 9.33 billion CNY and has achieved a year-to-date return of 22.77% [2] - The fund manager, Zhao Bei, has a cumulative tenure of 10 years and 335 days, with the fund's total asset scale at 16.425 billion CNY and a best return of 233.5% during her tenure [2]